Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Depreciation and Depletion (2016 - 2022)

Nu-Med Plus' Depreciation and Depletion history spans 10 years, with the latest figure at $2650.0 for Q4 2021.

  • On a quarterly basis, Depreciation and Depletion changed 0.0% to $2650.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $9364.0, a 20.6% decrease, with the full-year FY2022 number at $2267.0, down 75.79% from a year prior.
  • Depreciation and Depletion hit $2650.0 in Q4 2021 for Nu-Med Plus, roughly flat from $2649.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for NUMD hit a ceiling of $3803.0 in Q2 2018 and a floor of $1416.0 in Q2 2021.
  • Historically, Depreciation and Depletion has averaged $3090.5 across 5 years, with a median of $3091.0 in 2019.
  • Biggest five-year swings in Depreciation and Depletion: soared 100.67% in 2017 and later plummeted 53.54% in 2021.
  • Tracing NUMD's Depreciation and Depletion over 5 years: stood at $3585.0 in 2017, then grew by 5.27% to $3774.0 in 2018, then decreased by 19.55% to $3036.0 in 2019, then fell by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021.
  • Business Quant data shows Depreciation and Depletion for NUMD at $2650.0 in Q4 2021, $2649.0 in Q3 2021, and $1416.0 in Q2 2021.